| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |